BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33513422)

  • 21. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DKB114, A Mixture of
    Lee YS; Kim SH; Yuk HJ; Kim DS
    Nutrients; 2018 Sep; 10(10):. PubMed ID: 30274153
    [No Abstract]   [Full Text] [Related]  

  • 23. Catalysis and Structure of Zebrafish Urate Oxidase Provide Insights into the Origin of Hyperuricemia in Hominoids.
    Marchetti M; Liuzzi A; Fermi B; Corsini R; Folli C; Speranzini V; Gandolfi F; Bettati S; Ronda L; Cendron L; Berni R; Zanotti G; Percudani R
    Sci Rep; 2016 Dec; 6():38302. PubMed ID: 27922051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.
    Perez-Ruiz F; Herrero-Beites AM; Carmona L
    Arthritis Rheum; 2011 Dec; 63(12):4002-6. PubMed ID: 21898351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
    Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and biochemical insights into a hyperthermostable urate oxidase from Thermobispora bispora for hyperuricemia and gout therapy.
    Chiu YC; Hsu TS; Huang CY; Hsu CH
    Int J Biol Macromol; 2021 Oct; 188():914-923. PubMed ID: 34403675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
    Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
    Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a novel alkaline Arxula adeninivorans urate oxidase expressed in Escherichia coli and its application in reducing uric acid content of food.
    Zhang R; Gao SJ; Zhu CY; Sun Y; Liu XL; Zhao MM; Wang CH
    Food Chem; 2019 Sep; 293():254-262. PubMed ID: 31151609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia/Gout.
    Katayama A; Yokokawa H; Fukuda H; Ono Y; Isonuma H; Hisaoka T; Naito T
    Intern Med; 2019 May; 58(9):1225-1231. PubMed ID: 30626825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The kidney in hyperuricemia and gout.
    Mount DB
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):216-23. PubMed ID: 23318701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel enzymatic approach in the production of food with low purine content using Arxula adeninivorans endogenous and recombinant purine degradative enzymes.
    Jankowska DA; Trautwein-Schult A; Cordes A; Bode R; Baronian K; Kunze G
    Bioengineered; 2015; 6(1):20-5. PubMed ID: 25513995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
    Chohan S; Becker MA; MacDonald PA; Chefo S; Jackson RL
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):256-61. PubMed ID: 22052584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between serum allantoin and urate in healthy subjects and effects of benzbromarone in gout patients.
    Kurajoh M; Koyama H; Shoji T; Sumida C; Yamamoto A; Tsutsumi Z; Moriwaki Y; Yamamoto T; Koga M
    Int J Clin Pharmacol Ther; 2012 Apr; 50(4):265-71. PubMed ID: 22456297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current and future therapies for gout.
    Pascart T; Richette P
    Expert Opin Pharmacother; 2017 Aug; 18(12):1201-1211. PubMed ID: 28689430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineered
    Zhao R; Li Z; Sun Y; Ge W; Wang M; Liu H; Xun L; Xia Y
    Gut Microbes; 2022; 14(1):2070391. PubMed ID: 35491895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Protein Diet Induces Hyperuricemia in a New Animal Model for Studying Human Gout.
    Hong F; Zheng A; Xu P; Wang J; Xue T; Dai S; Pan S; Guo Y; Xie X; Li L; Qiao X; Liu G; Zhai Y
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gout treatment: should we aim for rapid crystal dissolution?
    Pascual E; Andrés M; Vela P
    Ann Rheum Dis; 2013 May; 72(5):635-7. PubMed ID: 23322814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uric acid, evolution and primitive cultures.
    Johnson RJ; Titte S; Cade JR; Rideout BA; Oliver WJ
    Semin Nephrol; 2005 Jan; 25(1):3-8. PubMed ID: 15660328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.
    Fleischmann R; Kerr B; Yeh LT; Suster M; Shen Z; Polvent E; Hingorani V; Quart B; Manhard K; Miner JN; Baumgartner S;
    Rheumatology (Oxford); 2014 Dec; 53(12):2167-74. PubMed ID: 24509406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interplay between diet, urate transporters and the risk for gout and hyperuricemia: current and future directions.
    Torralba KD; De Jesus E; Rachabattula S
    Int J Rheum Dis; 2012 Dec; 15(6):499-506. PubMed ID: 23253231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.